Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Endothelial apoptosis decrease following tadalafil administration in patients with arterial ED does not last after its discontinuation

International Journal of Impotence Research volume 23, pages 200–205 (2011)Cite this article

Subjects

Abstract

Although it is well known that phosphodiesterase V inhibitors, used to treat patients with ED, can improve the endothelial dysfunction in organic vascular forms, few studies have explored the duration of their effect on the endothelium after discontinuation. Therefore, the purpose of this study was to evaluate the serum concentrations of apoptotic endothelial microparticles (EMPa), selected as a marker of endothelial damage, in patients with arterial ED at baseline, during tadalafil administration and 3 and 6 months after its discontinuation. In all, 50 patients with arterial ED were evaluated at baseline and 1 week after administration of tadalafil 5 mg once daily for 90 days. Clinical (International Index of Erectile Function-5 score), instrumental (dynamic penile echo color Doppler) and flow-cytometric (serum EMPa concentrations) analyses were performed before (T0) and 1 week (T1), 3 months (T2) and 6 months (T3) after tadalafil discontinuation. The events CD45neg/CD144pos/annexinVpos were defined as EMPa. At T0, patients with arterial ED had serum EMPa concentration significantly higher than 20 healthy men (controls). At T1, patients with arterial ED showed a serum EMPa concentration significantly lower than T0. The significant difference was maintained, though reduced, at T2 and completely lost at T3. In conclusion, the administration of tadalafil decreased serum EMPa concentration in patients with arterial ED. This positive effect on the endothelial dysfunction disappeared 6 months after tadalafil discontinuation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Vicari E, Malaguarnera M, La Vignera S, Calzavara F, Battiato C, Calogero AE . Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and cardiovascular comorbidities. Asian J Androl 2008; 10: 847–853.

    Article  CAS  Google Scholar 

  2. Costa C, Virag R . The endothelial-erectile dysfunction connection: an essential update. J Sex Med 2009; 6: 2390–2404.

    Article  CAS  Google Scholar 

  3. Shet AS . Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag 2008; 4: 769–774.

    Article  Google Scholar 

  4. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A . Endothelial microparticles in diseases. Cell Tissue Res 2009; 335: 143–151.

    Article  Google Scholar 

  5. Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C et al. Insulin-like growth factor-1 as a vascular protective factor. Circulation 2004; 110: 2260–2265.

    Article  Google Scholar 

  6. Esposito K, Ciotola M, Giugliano F, Sardelli L, Giugliano F, Maiorino MI et al. Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J Sex Med 2008; 5: 1436–1442.

    Article  Google Scholar 

  7. Park K, Ryu KS, Li WJ, Kim SW, Paick JS . Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction. Eur Urol 2008; 53: 1282–1288.

    Article  CAS  Google Scholar 

  8. Lysiak JJ, Yang SK, Klausner AP, Son H, Tuttle JB, Steers WD . Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol 2008; 179: 779–785.

    Article  CAS  Google Scholar 

  9. Porst H, Glina S, Ralph D, Zeigler H, Wong DG, Woodward B . Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction. J Sex Med 2010; 7: 3487–3494.

    Article  CAS  Google Scholar 

  10. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM . Development and evaluation of an abridged, 5 item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.

    Article  CAS  Google Scholar 

  11. Benson CB, Aruny JE, Vickers Jr MA . Correlation of duplex sonography with arteriography in patients with erectile dysfunction. Am J Roentgenol 1993; 160: 71–73.

    Article  CAS  Google Scholar 

  12. Speel TG, van Langen H, Wijkstra H, Meuleman EJ . Penile duplex pharmaco-ultrasonography revisited: revalidation of the parameters of the cavernous arterial response. J Urol 2003; 169: 216–220.

    Article  CAS  Google Scholar 

  13. Ryu JK, Zhang LW, Jin HR, Piao S, Choi MJ, Tuvshintur B et al. Derangements in endothelial cell-to-cell junctions involved in the pathogenesis of hypercholesterolemia-induced erectile dysfunction. J Sex Med 2009; 6: 1893–1907.

    Article  CAS  Google Scholar 

  14. Vestweber D . VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008; 28: 223–232.

    Article  CAS  Google Scholar 

  15. Bernard S, Loffroy R, Sérusclat A, Boussel L, Bonnefoy E, Thévenon C et al. Increased levels of endothelial microparticles CD144 (VE-cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis 2009; 203: 429–435.

    Article  CAS  Google Scholar 

  16. Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A . The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 2010; 26: 140–145.

    Article  Google Scholar 

  17. Laufer EM, Reutelingsperger CP, Narula J, Hofstra L . Annexin A5: an imaging biomarker of cardiovascular risk. Basic Res Cardiol 2008; 103: 95–104.

    Article  CAS  Google Scholar 

  18. Porst H, Rajfer J, Casabé A, Feldman R, Ralph D, Vieiralves LF et al. Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction. J Sex Med 2008; 5: 2160–2169.

    Article  CAS  Google Scholar 

  19. Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G . Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 2007; 19: 200–207.

    Article  CAS  Google Scholar 

  20. Hatzichristou D, Gambla M, Rubio-Aurioles E, Buvat J, Brock GB, Spera G et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med 2008; 25: 138–146.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Systemic Diseases, Section of Endocrinology, Andrology and Internal Medicine, Master in Andrological, Human Reproduction and Biotechnology Sciences, University of Catania, Catania, Italy

    S La Vignera, R A Condorelli, E Vicari, R D'Agata & A E Calogero

Authors
  1. S La Vignera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R A Condorelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Vicari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R D'Agata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A E Calogero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S La Vignera.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

La Vignera, S., Condorelli, R., Vicari, E. et al. Endothelial apoptosis decrease following tadalafil administration in patients with arterial ED does not last after its discontinuation. Int J Impot Res 23, 200–205 (2011). https://doi.org/10.1038/ijir.2011.28

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2011.28

Keywords

This article is cited by

Search

Advanced search

Quick links